MiniMed Group Common Stock's receivables is $660M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (April 2026), MMED shows a receivables of $660M. That compares with $570M in the prior-year period — up 14.9% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, MMED's receivables is now $660M (was $570M) — a 14.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether MiniMed Group Common Stock is outperforming or lagging.
Tracking MMED's receivables over time shows whether MiniMed Group Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $660M That compares with $570M in the prior-year period — up 14.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has MiniMed Group Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $660M) with ownership activity and broader fundamentals.